MLchartDataset catalogue

Voraxaze

Term · Oncology and biomedicine · MLC-T-ONC-009317

A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Voraxaze is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Voraxaze is a type of chemoprotective agent and a type of prodrug activator. Also called carboxypeptidase-G2 and glucarpidase.

Table 1. Record
IdentifierMLC-T-ONC-009317
FieldOncology and biomedicine
Synonymscarboxypeptidase-G2; glucarpidase
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009317",
  "term": "Voraxaze",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Voraxaze is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Voraxaze is a type of chemoprotective agent and a type of prodrug activator. Also called carboxypeptidase-G2 and glucarpidase.",
  "synonyms": [
    "carboxypeptidase-G2",
    "glucarpidase"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/voraxaze/"
}

Record 17,338 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.